Ganglioside GM1 Deficiency in Effector T Cells From NOD Mice Induces Resistance to Regulatory T-Cell Suppression
Open Access
- 20 August 2011
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 60 (9), 2341-2349
- https://doi.org/10.2337/db10-1309
Abstract
OBJECTIVE: To detect GM1 deficiency and determine its role in effector T cells (Teffs) from NOD mice in establishing resistance to regulatory T-cell (Treg) suppression.RESEARCH DESIGN AND METHODS: CD4+ and CD8+ Teffs were isolated from spleens of prediabetic NOD mice for comparison with similar cells from Balb/c, C57BL/6, and NOR mice. GM1 was quantified with thin-layer chromatography for total cellular GM1 and flow cytometry for cell-surface GM1. Suppression of Teff proliferation was determined by application of GM1 cross-linking agents or coculturing with Tregs. Calcium influx in Teffs was quantified using fura-2.RESULTS: Resting and activated CD4+ and CD8+ Teffs of NOD mice contained significantly less GM1 than Teffs from the other three mouse strains tested. After activation, NOD Teffs resisted suppression by Tregs or GM1 cross-linking agents in contrast to robust suppression of Balb/c Teffs; this was reversed by preincubation of NOD Teffs with GM1. NOD Teffs also showed attenuated Ca2+ influx via transient receptor potential channel 5 (TRPC5) channels induced by GM1 cross-linking, and this, too, was reversed by elevation of Teff GM1.CONCLUSIONS: GM1 deficiency occurs in NOD Teffs and contributes importantly to failed suppression, which is rectified by increasing Teff GM1. Such elevation also reverses subthreshold Ca2+ influx via TRPC5 channels, an essential aspect of suppression. Our results also support a critical role for galectin-1 as a GM1 cross-linking counter-receptor that fittingly is upregulated and released by Tregs during activation. These findings suggest a novel mechanism by which pathogenic Teffs evade regulatory suppression, thereby leading to autoimmune β-cell destruction and type 1 diabetes.Keywords
This publication has 53 references indexed in Scilit:
- Cross-Linking of GM1 Ganglioside by Galectin-1 Mediates Regulatory T Cell Activity Involving TRPC5 Channel Activation: Possible Role in Suppressing Experimental Autoimmune EncephalomyelitisPublished by The American Association of Immunologists ,2009
- Suppression of Autoimmune Diabetes by Soluble Galectin-1The Journal of Immunology, 2009
- The defect in T-cell regulation in NOD mice is an effect on the T-cell effectorsProceedings of the National Academy of Sciences, 2008
- Circulating CD4+CD25high Regulatory T Cells and Natural Killer T Cells in Children with Newly Diagnosed Type 1 Diabetes or with Diabetes‐Associated AutoantibodiesAnnals of the New York Academy of Sciences, 2007
- Differential partitioning and trafficking of GM gangliosides and cholesterol-rich lipid rafts in thymic and splenic CD4 T cellsMolecular Immunology, 2007
- Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+regulatory T cellsImmunology, 2007
- Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cellsBlood, 2006
- Control of Type 1 Autoimmune Diabetes by Naturally Occurring CD4+CD25+Regulatory T Lymphocytes in Neonatal NOD MiceAnnals of the New York Academy of Sciences, 2005
- Galectin-1 and galectin-3 in fetal development of bovine respiratory and digestive tractsCell and tissue research, 2002
- Role of membrane gangliosides in the binding and action of bacterial toxinsThe Journal of Membrane Biology, 1982